Before you ask for a price
Why a single price is misleading
Search for the cost of private cancer treatment and you will find round numbers that look reassuringly precise. They are almost never what a real person pays. Cancer care is not one product with one price. It is a sequence of appointments, tests and treatments, each priced separately, and the sequence itself depends on the diagnosis, the stage and how the person responds. Two people with the same type of cancer can follow very different pathways, so a figure that was true for one of them tells the other very little.
Cancer Research UK describes private care as something people may use for all of their treatment or just part of it, either at a private hospital or as a private patient within an NHS hospital [1]. That flexibility is useful, but it also means there is no standard package to price. In researching this guide we did not find a current national tariff that covers a whole private cancer pathway, and we have not invented one. What we can do is show you how a bill is built, so you can read any quote critically.
The scale of the question is large. More than 403,000 people are diagnosed with cancer in the UK every year, around 1,100 a day, and Cancer Research UK projects that annual cases will pass 505,000 by 2038 to 2040 [5]. Most of them are treated by the NHS. A smaller number pay for some or all care themselves or claim on insurance, and it is that group this guide is written for.
What actually makes up a private cancer bill
Every private provider presents prices differently, but the same building blocks keep appearing. Some are charged by the hospital, some by individual consultants who invoice separately, and some by pharmacies or laboratories. Knowing which is which helps you spot what a "package" leaves out.
| Part of the bill | Who usually invoices | Why the amount varies |
|---|---|---|
| Specialist consultations | The consultant, often separately from the hospital | Number of appointments and the consultant’s own fee |
| Scans and tests | Hospital or imaging centre; laboratory for samples | Which scans are needed and how often they are repeated |
| Surgery | Hospital for theatre and stay; surgeon and anaesthetist separately | Procedure, length of stay and any return to theatre |
| Drug treatment | Hospital pharmacy or a homecare provider | The named medicine, dose, number of cycles and delivery setting |
| Radiotherapy | Cancer centre; planning may be billed separately | Number of sessions and the planning work involved |
| Follow-up and monitoring | Consultant and hospital | How long monitoring lasts and how many scans it includes |
The drug line is often the most uncertain. Some newer cancer medicines are available on the NHS only through managed access, a NICE arrangement that lets people receive promising treatments while more evidence is gathered on whether they are cost-effective [9]. Privately, the price of a medicine depends on what is prescribed and for how long, which is a clinical decision that cannot be known when you first ask about cost.
Why packages still leave gaps
A fixed-price package can be a useful anchor, but read its boundaries line by line. Ask whether it covers the consultant and anaesthetist as well as the hospital, how many follow-up appointments are included, and what happens if a complication means a longer stay. A package priced for a planned operation may say nothing about drug treatment or radiotherapy that follows it. The honest answer to "what will the whole thing cost?" is usually a set of quotes, one per stage.
How to get a quote you can rely on
The most useful document you can hold is an itemised written quote from a named provider, for a defined part of care, with a date. Verbal estimates on the phone are a starting point only. When you ask, make clear you want each element listed separately and you want to know what would change the price.
Step 1: Ask for the stage, not the whole journey
Request a price for the next defined step, such as a consultation and scans, or a specific operation, rather than an all-in estimate.
Step 2: Get every invoicer named
Ask which professionals bill separately from the hospital and request their fees in writing too.
Step 3: Ask what is excluded
Find out what the quote does not include, such as medicines taken home, extra nights or further scans.
Step 4: Ask what happens if plans change
Request the provider’s policy on price changes if the treatment plan alters part-way through.
Step 5: Check deposits and payment timing
Confirm when payment is due, whether a deposit is needed and what is refundable.
Step 6: Keep everything dated
File each quote with its date so you can compare like with like and challenge any later difference.
Mixing NHS and self-pay care
Many people do not choose between NHS and private care outright. They pay for one part, perhaps a faster consultation or a medicine not routinely funded, and continue with the NHS for the rest. Government guidance for the NHS in England sets out how this should work: NHS patients who buy additional private care should not lose NHS care they are already entitled to, but the private part must be delivered separately from the NHS part [8]. That guidance followed a review of access to medicines, which is one reason it matters most in cancer care.
In practice, keeping the two separate means separate appointments, separate records of payment and clarity about which team is responsible at each point. Ask both teams to confirm in writing how results and letters will be shared. If you are paying for a medicine privately, ask the NHS team how the rest of your care will continue alongside it.
Paying privately for part of cancer care
What works well
- You can buy a specific step, such as an earlier consultation, without committing to a whole private pathway.
- NHS entitlement to the rest of your care continues under the DHSC guidance [8].
- A written quote for one step is easier to check and compare than an open-ended estimate.
What to watch
- Moving between systems needs careful coordination of records and responsibility.
- One private step can lead to further private costs you had not planned for.
- Prices for medicines and later stages may not be knowable at the outset.
The costs that never appear on a hospital invoice
A Macmillan report found that 83% of people living with cancer were affected financially, and that they were on average £570 a month worse off; 45% said the size of the impact had taken them by surprise [6]. Those figures cover everyone with cancer, not only people paying privately, and they come from 2019, so treat them as an indication of scale rather than a current price. They are a useful reminder that the hospital bill is only one line in the household budget.
- Travel and parking for repeated appointments, which add up across a course of treatment.
- Time off work, for you and sometimes for a partner or family member who comes with you.
- Lost income if you reduce hours, especially if you are self-employed.
- Prescriptions, although in England people having treatment for cancer, its effects or the effects of treatment can apply for a five-year medical exemption certificate that makes NHS prescriptions free [7].
Macmillan explains that people affected by cancer may be able to claim benefits to help with extra costs or if they need to stop working, and its support line can talk through what applies [11]. If you have income protection or critical illness cover, read how critical illness cover works alongside this guide, because those policies pay you rather than the hospital.
How insurance changes the bill
Private medical insurance does not make cancer care cheaper. It changes who pays. When a claim is eligible, the insurer usually settles approved charges with the provider, and you pay any excess and anything outside your cover. Insurers build their cancer benefits differently. AXA Health sells cancer care as an option and states it will not cover a cancer you have already had, even if it returns or spreads [10]. Aviva publishes a cancer pledge that names chemotherapy, radiotherapy and targeted therapy [2]. WPA offers cancer care as an optional extra on its Complete Health plan [3].
Because of those differences, the useful question is not "am I covered for cancer?" but "which parts of this quote would my policy pay, and what would be left?" Our guide to limits on private cancer cover walks through the boundaries to check, and making a cancer claim covers the approval steps.
How NHS waiting figures fit in
Many people look at private costs because they are worried about waiting. NHS England publishes monthly cancer waiting times. Cancer Research UK’s analysis of the August 2026 figures reported that 78.6% of people were diagnosed or had cancer ruled out within 28 days of an urgent referral, against an 80% target, and that 92.1% started treatment within 31 days of a decision to treat, against a 96% target [4].
- 28-day diagnosis (target 80%)78.6%
- 31-day treatment (target 96%)92.1%
- 62-day treatment (target 85%)71.9%
These are national averages for England. They describe how the NHS performs across hundreds of thousands of people, not how long any one person will wait, and they say nothing about private waiting times. If speed is your main reason for considering private care, ask a named private provider for an actual available date before you pay anything.
Looking at cover with PremierPMI
PremierPMI is a specialist private medical insurance broker and the publisher of The Health Guide. If you want to talk through what this means for your own cover, you can start there.
Or, if you would rather start here, send an enquiry and PremierPMI will contact you.
Common questions
Why won’t private hospitals give me one total price for cancer treatment?
Can I pay for some cancer care privately and keep my NHS treatment?
Are cancer prescriptions free on the NHS?
Does health insurance pay the whole cost of private cancer treatment?
What hidden costs come with cancer apart from treatment?
Is it worth getting several quotes for private cancer care?
Where can I get help with the cost of cancer?
Sources and methodology
- [1] Cancer Research UK. “Private cancer treatment”. View source(opens in a new tab)Primary source
- [2] Aviva. “Our cancer pledge”. View source(opens in a new tab)Primary source
- [3] WPA. “Complete Health policy brochure”. View source(opens in a new tab)Primary source
- [4] Cancer Research UK. “Cancer waiting times: latest updates and analysis”. View source(opens in a new tab)Primary source
- [5] Cancer Research UK. “All cancers combined incidence statistics”. View source(opens in a new tab)Primary source
- [6] Macmillan Cancer Support. “Cancer – a costly diagnosis?”. View source(opens in a new tab)Primary source
- [7] NHS Business Services Authority. “Medical exemption certificates”. View source(opens in a new tab)Primary source
- [8] Department of Health and Social Care. “Guidance on NHS patients who wish to pay for additional private care”. View source(opens in a new tab)Primary source
- [9] National Institute for Health and Care Excellence. “Managed access”. View source(opens in a new tab)Primary source
- [10] AXA Health. “Cancer cover health insurance”. View source(opens in a new tab)Primary source
- [11] Macmillan Cancer Support. “Benefits and financial support”. View source(opens in a new tab)Primary source
We cite primary sources wherever possible. Read about our sourcing methodology.

Emma Leadbetter
Editor and Copywriter, PremierPMI
- 15 years health, finance and consumer journalism
- PhD candidate, University of Chichester
Emma has written across health, finance and consumer-affairs journalism for more than 15 years, and has been part of the PremierPMI team since 2022. She is known for making complex topics easy to understand, and fact-checks every guide against current insurer wording before it goes live. She is completing a PhD at the University of Chichester researching how the NHS has changed since COVID-19.
Read full profile
Stuart Hendy
PMI Expert and Head of Publishing, PremierPMI
- 20 years in UK private medical insurance
- Underwriting and corporate placement specialist
Stuart brings over 20 years of experience advising on UK private medical insurance. He is a key member of the private medical insurance team and Head of the Publishing Team, gathering detailed client requirements, liaising with insurers on tailored quotes, and running training on insurer product changes and underwriting nuance.
Read full profile






